A detailed history of Pictet Asset Management Sa transactions in Iveric Bio, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 24,966 shares of ISEE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,966
Previous 2,316,300 98.92%
Holding current value
$0
Previous $56.4 Million 98.26%
% of portfolio
0.0%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$26.24 - $39.63 $60.1 Million - $90.8 Million
-2,291,334 Reduced 98.92%
24,966 $982,000
Q1 2023

May 10, 2023

BUY
$18.67 - $24.56 $43 Million - $56.5 Million
2,302,337 Added 16488.84%
2,316,300 $56.4 Million
Q4 2022

Feb 13, 2023

BUY
$17.24 - $23.95 $240,722 - $334,413
13,963 New
13,963 $299,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.